BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 1685444)

  • 1. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS
    Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
    Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
    Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
    Lehväslaiho H; Lehtola L; Sistonen L; Alitalo K
    EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ras gene activation in rat tumors induced by benzidine congeners and derived dyes.
    Reynolds SH; Patterson RM; Mennear JH; Maronpot RR; Anderson MW
    Cancer Res; 1990 Jan; 50(2):266-72. PubMed ID: 2403837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the proto-neu oncogene facilitates oncogenic activation by a single point mutation.
    Hung MC; Yan DH; Zhao XY
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2545-8. PubMed ID: 2565034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene.
    Reardon DB; Hung MC
    J Biol Chem; 1993 Aug; 268(24):18136-42. PubMed ID: 7688739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression during multistage carcinogenesis.
    Bowden GT; Krieg P
    Environ Health Perspect; 1991 Jun; 93():51-6. PubMed ID: 1773801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming activity of DNA from rat liver tumors induced by the carcinogen methyl(acetoxymethyl)nitrosamine.
    Goyette M; Dolan M; Kaufmann W; Kaufman D; Shank PR; Fausto N
    Mol Carcinog; 1988; 1(1):26-32. PubMed ID: 2855600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
    Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
    Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
    J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region.
    Ohuchi T; Kurita Y; Sasai H; Miyoshi J; Nomura T; Toyoshima K
    Oncogene; 1992 Feb; 7(2):331-8. PubMed ID: 1532243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.
    Devereux TR; Foley JF; Maronpot RR; Kari F; Anderson MW
    Carcinogenesis; 1993 May; 14(5):795-801. PubMed ID: 8504471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
    Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
    Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
    Sikes RA; Chung LW
    Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.